Espo


Indications and Reactions:

Role Indications Reactions
Primary
Anaemia Neonatal 100.0%
Retinopathy Of Prematurity 100.0%
Secondary
Product Used For Unknown Indication 53.3%
Drug Use For Unknown Indication 20.0%
Nephrogenic Anaemia 20.0%
Procedural Hypertension 6.7%
Aplasia Pure Red Cell 61.5%
Anti-erythropoietin Antibody Positive 23.1%
Toxic Skin Eruption 15.4%
Concomitant
Hypertension 25.7%
Prophylaxis 8.9%
Product Used For Unknown Indication 8.2%
Nephrogenic Anaemia 7.4%
Hepatitis C 6.0%
Herpes Zoster 5.0%
Hyperuricaemia 5.0%
Constipation 4.9%
Pneumonia 4.5%
Hyperkalaemia 2.8%
Gastritis 2.7%
Renal Cell Carcinoma Stage Iv 2.5%
Acute Myocardial Infarction 2.4%
Fluid Replacement 2.2%
Infection 2.2%
Nutritional Support 2.2%
Asthma 1.9%
Chronic Hepatitis C 1.9%
Hyperphosphataemia 1.9%
Irritable Bowel Syndrome 1.9%
Upper Gastrointestinal Haemorrhage 14.5%
Pyrexia 13.6%
Decreased Appetite 7.3%
Renal Impairment 7.3%
Cerebral Haemorrhage 6.4%
Renal Failure 6.4%
Anaemia 5.5%
Restlessness 4.5%
White Blood Cell Count Increased 4.5%
Drug Exposure Via Breast Milk 3.6%
Drug Ineffective 3.6%
Muscular Weakness 3.6%
White Blood Cell Count Decreased 3.6%
Surgery 2.7%
Tonic Convulsion 2.7%
Vomiting 2.7%
Aplasia Pure Red Cell 1.8%
Embolic Cerebral Infarction 1.8%
Enteritis Infectious 1.8%
Hypoxia 1.8%

Drug Data